Surgery News and Research

RSS

Mount Sinai neuroscientist sheds light on how the brain stores memories across a lifetime

Denise Cai, PhD, an Assistant Professor of Neuroscience at the Icahn School of Medicine at Mount Sinai, has always been interested in the dynamic nature of memory. But she began to question precisely how the brain can store and recall so many memories over a lifetime while playing a "memory match" card game with her young son.

1 Oct 2019

Detecting neurocognitive change in children with acute lymphoblastic leukemia

Although cure rates for children with cancer are increasing, cancer treatments can cause permanent deterioration of brain functions leading to impairments in attention, concentration, memory and learning. As a result, these changes can lead to challenges with school, obtaining future employment and overall quality of life into adulthood, even though cancer treatment may have been successful.

1 Oct 2019

US Department of Defense provides support to develop AI tools for saving lives of badly injured soldiers

The US Department of Defense has awarded the Centre for Trauma Sciences at Queen Mary a $1.2 million (£976.500) grant to develop AI tools that could help save the lives of badly injured soldiers.

1 Oct 2019

New round of Medicare readmission penalties hits 2,583 hospitals

Medicare cut payments to 2,583 hospitals Tuesday, continuing the Affordable Care Act's eight-year campaign to financially pressure hospitals into reducing the number of patients who return for a second stay within a month.

1 Oct 2019

Mount Sinai researchers receive NIH award to develop universal flu vaccine

Researchers at the Icahn School of Medicine at Mount Sinai have received a contract award of up to $132 million from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH), as part of a new Collaborative Influenza Vaccine Innovation Centers (CIVICs) program to further develop the universal flu vaccine.

1 Oct 2019

Johns Hopkins Medicine celebrates opening of Pavilion III at Green Spring Station

As part of an $80 million expansion at Green Spring Station, Johns Hopkins Medicine celebrated the official opening of the newly built Pavilion III at Green Spring Station with a private grand opening event on Sept. 27 and a free community health fair on Sept. 28.

1 Oct 2019

Analyses of two clinical trials predict response to asthma drug by COPD patients

Chronic obstructive pulmonary disease, or COPD, is the third leading cause of death in the U.S., according to the American Lung Association.

30 Sep 2019

Addressing the evidence behind various therapeutic options for adolescents with obesity

As rates of adolescent obesity continue to rise, choice of treatment needs to be guided by the severity of obesity, psychosocial factors, comorbidities and patient's age and pubertal status, according to a new paper published online in the Journal of the American Medical Association.

30 Sep 2019

New imaging technology may help surgeons better detect cancer during surgery

University of Texas at Dallas researchers have demonstrated that imaging technology used to map the universe shows promise for more accurately and quickly identifying cancer cells in the operating room.

30 Sep 2019

Women are needlessly dying from heart attacks due to substandard care

New evidence collected by the British Heart Foundation highlights a gender health gap at every stage of the medical journey when it comes to heart attacks.

30 Sep 2019

Using X-ray-nanoparticle interactions for improved radiation therapy

A new study has indicated a new way to deliver locally aggressive radiation therapy in cancer, using the element gadolinium.

30 Sep 2019

Baylor Scott & White opens newest full-service hospital in Buda

Baylor Scott & White Health, the largest not-for-profit healthcare system in Texas, opened its newest full-service hospital. Baylor Scott & White Medical Center – Buda, the System's first medical center in Hays County, is located at 5330 Overpass Road and is open 24 hours a day, 7 days a week.

30 Sep 2019

High-risk surgical patients with severe aortic stenosis can benefit from new TAVR system

The Portico IDE study found that 30-day safety and one-year effectiveness outcomes of a novel self-expanding transcatheter aortic valve replacement (TAVR) system for patients with severe aortic stenosis (AS) at high or extreme-risk for surgery was noninferior to contemporary FDA-approved TAVR systems available in the United States.

30 Sep 2019

Antibiotic-resistant bacteria could be transmitted via the washing machine

Hygienists of the University of Bonn prove a transmission to newborns. Consequences for the domestic environment?

30 Sep 2019

Study: Revascularization with PCI or CABG prolongs survival in patients with left main disease

Patients with left main coronary artery disease (LMCAD) typically have a poor prognosis due to the large amount of myocardium at risk.

30 Sep 2019

'Good' cholesterol reverses atherosclerosis in the blood vessels of mice with diabetes

Increasing levels of a simplified version of "good" cholesterol reversed disease in the blood vessels of mice with diabetes, a new study finds.

30 Sep 2019

New imaging systems can help diagnose heart disease

Researcher and professor Lasse Løvstakken starts a video on his computer screen. We're in the eye of a storm. It looks almost like a hurricane approaching a coastline.

30 Sep 2019

Additional heart artery stenting can help prevent future heart attacks

Research has shown that patients who have had emergency heart attack treatment with heart artery stenting - and have significant narrowings in their other untreated arteries - can benefit from additional stenting to help prevent future heart attacks.

28 Sep 2019

Novel therapeutic approach improves survival in patients newly diagnosed with advanced ovarian cancer

An international study demonstrates that administering niraparib after conventional chemotherapy treatment in patients newly diagnosed with advanced ovarian cancer, improves their progression-free survival, and reduces their risk of relapse or death from this disease.

28 Sep 2019

PARP inhibitor combined with chemotherapy increases survival for newly diagnosed ovarian cancer patients

Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that initial treatment with the PARP inhibitor veliparib in combination with chemotherapy significantly increased progression-free survival for patients with newly diagnosed, metastatic high-grade serous ovarian cancer, according to the results of the VELIA trial.

28 Sep 2019

Surgery News and Research

Mount Sinai neuroscientist sheds light on how the brain stores memories across a lifetime

Detecting neurocognitive change in children with acute lymphoblastic leukemia

US Department of Defense provides support to develop AI tools for saving lives of badly injured soldiers

New round of Medicare readmission penalties hits 2,583 hospitals

Mount Sinai researchers receive NIH award to develop universal flu vaccine

Johns Hopkins Medicine celebrates opening of Pavilion III at Green Spring Station

Analyses of two clinical trials predict response to asthma drug by COPD patients

Addressing the evidence behind various therapeutic options for adolescents with obesity

New imaging technology may help surgeons better detect cancer during surgery

Women are needlessly dying from heart attacks due to substandard care

Using X-ray-nanoparticle interactions for improved radiation therapy

Baylor Scott & White opens newest full-service hospital in Buda

High-risk surgical patients with severe aortic stenosis can benefit from new TAVR system

Antibiotic-resistant bacteria could be transmitted via the washing machine

Study: Revascularization with PCI or CABG prolongs survival in patients with left main disease

'Good' cholesterol reverses atherosclerosis in the blood vessels of mice with diabetes

New imaging systems can help diagnose heart disease

Additional heart artery stenting can help prevent future heart attacks

Novel therapeutic approach improves survival in patients newly diagnosed with advanced ovarian cancer

PARP inhibitor combined with chemotherapy increases survival for newly diagnosed ovarian cancer patients

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News